News article

The latest stories about hormones

Clinical Data Show Long Acting Human Growth Hormone ARX201 Is Safe And Well Tolerated (Medical News Today, 14 November 2008)

18 Nov 2008


Results of a phase I/II clinical trial by Ambrx Inc. showing that ARX201, the company's long-acting human growth hormone (hGH) analogue, normalised insulin-like growth factor I (IGF-I) levels, were presented at the International Congress of Endocrinology Conference in Rio de Janeiro.

Full article


Contents